Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine

Journal of Nuclear Medicine

Volumn 39, Issue 5, 1998, Pages 778-785

  Kaschten, Bruno ^a,b   Stevenaert, Achille ^a   Sadzot, Bernard ^a   Deprez, Manuel ^a   Degueldre, Christian ^a   Del Fiore, Guy ^a   Luxen, André ^a   Reznik, Michel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Brain neoplasms; Carbon 11 methionine; Fluorine 18 fluorode oxyglucose; Gliomas; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHIONINE C 11;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TOMOGRAPHY; CAMERA; CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TUMOR LOCALIZATION;

BRAIN; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; MALE; METHIONINE; MIDDLE AGED; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031968208     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 18F]fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-1329.
2. 18F]fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 1986;22:360-371.
3. Di Chiro G, Oldfield E, Wright DC, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologtc studies. Am J Neuroradiology 1987;8:1083-1091.
4. 18F]fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 1982;144:885-889.
5. Patronas NJ, Di Chiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816-822.
6. 11C-methionine and positron emission tomography. Am J Neuroradiology 1985;6:505-514.
7. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 1988;62:1074-1078.
8. Chatel M, Bustany P, Derlon JM. Métabolisme des tumeurs cérébrales in vivo: apports de la tomographie par émission de positons. In: Laffont A, Durlex F, eds. Encyclopédie medico-chirurgicale; neurologie, vol. 5. Paris: Editions Techniques; 1990:17210.
9. Delbeke D, Meyerowitz C, Lapidus RL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995;195:47-52.
10. Kaschten B, Sadzot B, Stevenaert A. Positron emission tomography. In: Palmer JD, ed. Neurosurgery 96: manual of neurosurgery. Edinburgh: Churchill Livingstone; 1996: 85-90.
11. Rigo P, Paulus P, Kaschten B, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-1674.
12. 68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 1985;9:683-689.
13. 11C-methionine. Am J Neuroradiology 1996;17:345-353.
14. 11C-L-methionine. Neurosurgery 1997;40:276-288.
15. Herholtz K, Pietrzyk U, Voges J, et al. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 1993;79:853-858.
16. Schifter T, Huffman JM, Hanson MW, et al. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 1993;17: 509-516.
17. 18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 1996;39:470-477.
18. 11C]L-methionine uptake in gliomas. Neurosurgery 1989;25:720-728.
19. Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993;186:45-53.
20. Fulham MJ, Brunetti A, Aloj L, Raman R, Dwyer AJ, Di Chiro G. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. J Neurosurg 1995;83:657-664.
21. Theodore WH, Di Chiro G, Margolin R, Fishbein D, Porter RJ, Brooks RA. Barbiturates reduce human cerebral glucose metabolism. Neurology 1986;36:60-64.
22. Theodore WH, Bairaman D, Newmark ME, et al. Effect of phenytoin on human cerebral glucose metabolism. J Cereb Blood Flow Metab 1986;6:315-320.
23. Theodore WH, Bromfield E, Onorati L. The effect of carbamazepine on cerebral glucose metabolism. Ann Neural 1989;25:516-520.
24. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. World Health Organization international classification of tumors. Berlin: Springer Verlag: 1993.
25. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproductive method. Cancer 1988;62:2152-2165.
26. Sokoloff L, Reivich M, Kennedy C, et al. The [C-14]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
27. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurements of local cerebral glucose metabolic rate in humans with [F-18]-2-fluoro-2-deoxy-D-glucose: validation of the method. Ann Neural 1979;6:371-388.
28. Di Chiro G, Brooks RA. PET quantitation: blessing and curse. J Nucl Med 1988;29:1603-1604.
29. Fulham MJ, Melisi JW, Nishimiya J, Dwyer AJ, Di Chiro G. Neuroimaging of juvenile pilocytic astrocytomas: an enigma. Radiology 1993;189:221-225.
30. Del Fiore G, Peeters JM, Quaglia L, et al. Automated preparation of carbon-11 ethanol and carbon-11 butanol for human studies using positron emission tomography. J Radioanal Nucl Chem 1986;104:301-316.